The results revealed overexpression of MAEL in 53% (76/143) of EOC specimens, 30% (6/20) of borderline tumor specimens, and 10% (3/30) of cystadenoma specimens, but no overexpression in normal ovarian tissues (p < 0.001, Table 1, Fig. 1B). The gene discussed is MAEL; the disease is cystadenoma.